Alzheimer's disease Archimedes condition-event simulator: Development and validation

Citations of this article
Mendeley users who have this article in their library.


Introduction: Several advances have been made in Alzheimer's Disease (AD) modeling, however, there remains a need for a simulator that represents the full scope of disease progression and can be used to study new disease-modifying treatments for early-stage and even prodromal AD. Methods: We developed AD Archimedes condition-event simulator, a patient-level simulator with a focus on simulating the effects of early interventions through changes in biomarkers of AD. The simulator incorporates interconnected predictive equations derived from longitudinal data sets. Results: The results of external validations on AD Archimedes condition-event simulator showed that it provides reasonable estimates once compared to literature results on transition to dementia AD, institutionalization, and mortality. A case study comparing a disease-modifying treatment and a symptomatic treatment also showcases the benefits of early treatment. Discussion: The AD Archimedes condition-event simulator is designed to perform economic evaluation on various interventions through close tracking of disease progression and the related clinical outcomes.




Kansal, A. R., Tafazzoli, A., Ishak, K. J., & Krotneva, S. (2018). Alzheimer’s disease Archimedes condition-event simulator: Development and validation. Alzheimer’s and Dementia: Translational Research and Clinical Interventions, 4, 76–88.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free